Seven patients, mostly adolescents, presented with agitation and psychotic features after unknowingly vaping a synthetic cannabinoid (MDMB-4en-PINACA) through contaminated e-cigarettes.
Emergency physicians, parents, school health officials, vaping product regulators.
Median age 17 years
What the researchers found
Seven patients (median age 17, range 14-37) presented to UK hospitals after using vaping products contaminated with MDMB-4en-PINACA. Six were male (85.7%). Five presented with unusual behavior changes; six were agitated; four displayed psychotic features including hallucinations and delusions. In three cases, MDMB-4en-PINACA was the only substance detected, confirming the vape as the sole source.
Why it matters
Vaping devices are increasingly being contaminated with synthetic cannabinoids, creating a hidden danger for users who believe they are vaping nicotine or standard cannabis products. The predominance of adolescent patients in this series highlights the vulnerability of young people to this emerging threat.
The numbers in context
7 patients. Median age 17 years (range 14-37). 85.7% male. 71.4% presented with behavioral changes. 85.7% agitated. 57.1% had psychotic features. 3 cases: MDMB-4en-PINACA was the only substance detected. Period: Feb 2022-Feb 2025.
How the study worked
Observational case series from two UK acute hospitals (February 2022-February 2025). Patients self-reported vaping product use and were found positive for MDMB-4en-PINACA on routine toxicological urine screening. Clinical presentations were documented.
What this study cannot tell us
Very small case series (N=7). Observational without controls. Cannot determine prevalence of contaminated vaping products. Limited to two hospitals in one country. Routine screening may miss cases where clinicians do not test for synthetic cannabinoids.
How to read the evidence
Preliminary: small case series providing important clinical alert but limited generalizability.
When this study was published
2025 study (cases from 2022-2025)
The bigger picture
The contamination of legal vaping products with potent synthetic cannabinoids represents an emerging public health concern. Unlike intentional synthetic cannabinoid use, these patients may not have known what they were consuming, making this a product safety issue as much as a substance use issue.
Questions still open
- How widespread is synthetic cannabinoid contamination of vaping products? Should routine drug screening in young patients presenting with acute psychosis include synthetic cannabinoids? What supply chain interventions could prevent contamination?
Common questions
Can vaping devices contain synthetic cannabinoids?
What happened to the patients?
Read the original research
Seven patients with analytically confirmed MDMB-4en-PINACA toxicity associated with the use of electronic vaping devices.
Clinical toxicology (Philadelphia, Pa.), 63(5), 360-362
Citation
Pucci, Mark; Moyns, Emma; Welby-Everard, Peter; Starbrook, Lauren. (2025). Seven patients with analytically confirmed MDMB-4en-PINACA toxicity associated with the use of electronic vaping devices.. Clinical toxicology (Philadelphia, Pa.), 63(5), 360-362. https://doi.org/10.1080/15563650.2025.2489079
Explore the wider topic
- THC Purity and Potency: What the Label Actually Means
- Dab and Concentrate Withdrawal: Why It Hits Harder
- Delta-8 THC: Addiction, Withdrawal, and What We Don't Know
- Edible Addiction and Withdrawal: What Makes It Different
- Edibles and Psychosis: When a Bad Trip Becomes an Emergency
- Vaping vs Smoking vs Edibles: A Harm Reduction Guide
- How Cannabis Products Are Made: From Plant to Concentrate to Edible
- Laced Weed and Contaminated Vapes: Real Risks vs Myths
- Legal vs Street Weed: Quality, Safety, and What You're Actually Smoking
- Quitting Weed Pens and Dabs: Why Concentrates Hit Different
- Quitting Edibles: Is Withdrawal Different from Smoking?
- Sativa vs Indica: The Myth and the Science Behind Cannabis Strain Labels
- Why Is Weed Withdrawal Worse Now Than 20 Years Ago?